Sort
15,273 grants matching “antimicrobial resistance”
Innate immunity-based screen for bacterial type III secretion system inhibitors
$375,180Victoria Auerbuch Stone · University Of California Santa Cruz · R01 · FY2016 · AI
Characterizing the targets of phagocytic superoxide in Salmonella
$375,170James M. Slauch · University Of Illinois At Urbana-Champaign · R01 · FY2017 · AI
Characterizing the targets of phagocytic superoxide in Salmonella
$375,170James M. Slauch · University Of Illinois At Urbana-Champaign · R01 · FY2019 · AI
Characterizing the targets of phagocytic superoxide in Salmonella
$375,170James M. Slauch · University Of Illinois At Urbana-Champaign · R01 · FY2016 · AI
Innate Immune Defense against Clostridium Difficile Infection
$375,164Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2012 · AI
Biologically Active Cyclic Peptides
$375,123Dale L Boger · Scripps Research Institute, The · R01 · FY2012 · CA
The diverse contribution of TLR pathways to intestinal homeostasis
$375,123Eyal Raz · University Of California, San Diego · R01 · FY2010 · AI
Cathelicidins in Skin Immunity
$375,123Richard L Gallo · University Of California, San Diego · R01 · FY2010 · AI
Chemistry and Biology of Bacterial Sulfonucleotide Reductases
$375,052Kate Suzanne Carroll · Scripps Florida · R01 · FY2021 · GM
Class II MHC Transport and Function
$375,049Clifford V Harding · Case Western Reserve University · R01 · FY2007 · AI
Bacterial ribosome heterogeneity and gene expression
$375,010Kathryn Mary Ramsey · University Of Rhode Island · R35 · FY2023 · GM
Beta Lactamase Mutations in Antibiotic Resistance
$375,000Timothy Palzkill · Baylor College Of Medicine · R37 · FY2006 · AI
Antimicrobial agents directed against L11/23S rRNA
$375,000Isis Pharmaceuticals, Inc. · R44 · FY2002 · AI
Aminoglycoside Resistance in Bacteria
$375,000Sergei Vakulenko · University Of Notre Dame · R01 · FY2015 · AI
Understanding Evolution of Protein Function Through Design.
$375,000Ivan V Korendovych · Syracuse University · R35 · FY2018 · GM
Understanding Evolution of Protein Function Through Design.
$375,000Ivan V Korendovych · Syracuse University · R35 · FY2020 · GM
Excellence in Research for Emerging and Reemerging Diseases of Public Health Interest in Colombia at the National Institute of Health
$375,000Martha Ospina · Colombian National Institute Of Health · U01 · FY2022 · GH
Class A Carbapenemases
$375,000Sergei Vakulenko · University Of Notre Dame · R01 · FY2014 · AI
Structure-Function of the Shigella dysenteriae heme uptake operon (shu)
$375,000Angela None Wilks · University Of Maryland Baltimore · R01 · FY2010 · AI
Identification of Bacterial Resistance Mechanisms to Antimicrobial Chemokines
$375,000David L. Erickson · Brigham Young University · R15 · FY2012 · AI
Inhibition of human neutrophil function by Francisella tularensis
$375,000Lee-Ann H. Allen · University Of Iowa · R01 · FY2008 · AI
Class A Carbapenemases
$375,000Sergei Vakulenko · University Of Notre Dame · R01 · FY2015 · AI
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
$375,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
Aminoglycoside Resistance in Bacteria
$375,000Sergei Vakulenko · University Of Notre Dame · R01 · FY2012 · AI
Class A Carbapenemases
$375,000Sergei Vakulenko · University Of Notre Dame · R01 · FY2012 · AI